PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 21, 2016, Pressure BioSciences, Inc. (the Company)
held a special meeting in lieu of the annual meeting of
stockholders (the Meeting). At the Meeting, the stockholders
voted on the following proposals described in detail in the
Companys definitive information statement for the Meeting filed
with the Securities and Exchange Commission on November 15, 2016.
As of the record date for the Meeting, there were 30,468,862
shares of the Companys common stock, par value $0.01 per share,
issued and outstanding and entitled to one vote for each share
held. The holders of 82.05% of the Companys shares of common
stock outstanding (24,999,568) submitted votes by proxy or in
person at the Meeting, constituting a quorum.

Proposal 1 Elect two directors as Class II Directors
until the 2019 Annual Meeting of Stockholders. The election of
each director was approved as follows:

Proposal 2: Ratify the appointment of MaloneBailey LLP
as the Companys independent auditors for fiscal year 2016. The
ratification of the appointment of MaloneBailey LLP as the
Companys independent auditor for fiscal year 2016 was approved as
follows:

Proposal 3: Approval of an amendment to our articles
of organization to increase the authorized number of shares of
Common Stock by up to 50,000,000 shares, such increase to be
effected through one or more amendments to our articles of
organization to be filed with the Secretary of the Commonwealth
of Massachusetts at the discretion of the Board of Directors at
any time during the twelve months following the date of the
meeting. The authorized shares of Common Stock amendment was
approved as follows:

Proposal 4: Approval of an amendment to our articles
of organization to effect a reverse stock split of our Common
Stock by a ratio of not less than one-for-two and not more than
one-for-thirty at any time within twelve months following the
Meeting for the purpose of assisting the Company in meeting the
listing requirements of the Nasdaq Capital Market or another
exchange, with the decision of whether or not to implement a
reverse stock split and the exact ratio to be set at a whole
number within this range to be made by our Board of Directors in
its sole discretion. The reverse stock split amendment was
approved as follows:

Proposal 5: Approval, on an advisory basis, of a
non-binding resolution to approve the compensation of our named
executive officers. The non-binding resolution was approved as
follows:

Proposal 6: Approval of an adjournment of the Meeting,
if necessary or appropriate, to solicit additional proxies, in
the event that there are not sufficient votes at the time of such
adjournment to approve any of Proposal Nos. 1 through 5. The
adjournment was approved as follows:

About PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO)

Pressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources. Its laboratory instrument, the Barocycler, and its consumables product line, which include its Pressure Used to Lyse Samples for Extraction (PULSE) tubes, and other processing tubes, and application specific kits, such as consumable products and reagents, together make up its PCT Sample Preparation System (PCT SPS). The Company is also the distributor for the Constant Systems cell disruption equipment, parts, and consumables.

PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO) Recent Trading Information

PRESSURE BIOSCIENCES, INC. (OTCMKTS:PBIO) closed its last trading session down -0.010 at 0.190 with 92,800 shares trading hands.